HonCode

Go Back   HER2 Support Group Forums > her2group
Register Gallery FAQ Members List Calendar Today's Posts

 
 
Thread Tools Display Modes
Prev Previous Post   Next Post Next
Old 03-27-2010, 03:55 PM   #1
Christine MH-UK
Senior Member
 
Join Date: Sep 2005
Posts: 414
CEP17 seems to be key to anthracycline susceptibility

I figured that this one is a pretty important answer to a pretty major question: who actually benefits from those potentially cardiotoxic anthracyclines.

http://www.eurekalert.org/pub_releas...-nwd032410.php

As someone who had a very minimal response to anthracyclines and an unusually high level of side effects, I am glad to see that a charity I support Cancer Research UK, has helped answer this question. Might even send them a well done letter!
Christine MH-UK is offline   Reply With Quote
 


Posting Rules
You may not post new threads
You may not post replies
You may not post attachments
You may not edit your posts

BB code is On
Smilies are On
[IMG] code is On
HTML code is Off

Forum Jump


All times are GMT -7. The time now is 10:28 PM.


Powered by vBulletin® Version 3.8.7
Copyright ©2000 - 2024, vBulletin Solutions, Inc.
Copyright HER2 Support Group 2007 - 2021
free webpage hit counter